Interactive Satellite:
New Frontiers in NIH AIDS Research
Sunday, July 22, 11:15 a.m.-1:15 p.m., Session Room 6
Watch the webcast of this session!
Tremendous progress has been made in HIV prevention and treatment research in recent years, but we remain far from declaring victory against AIDS. What are some of the key AIDS research challenges before us? How is NIH working to develop and improve upon the most effective HIV prevention and treatment tools, including:
- Better methods to prevent and treat HIV-associated coinfections, malignancies, and complications
- Improved biomedical and behavioral prevention tools, including microbicides and vaccines
- Strategies to understand the factors that affect HIV vulnerability, treatment outcomes, and disease progression among different populations
- New treatment and prevention strategies for substance users
- Approaches to overcome drug resistance and treatment failure and eradicate persistent HIV viral reservoirs that may one day lead to a cure for HIV disease.
PANELISTS INCLUDE:
| Dr. Francis Collins | Director, National Institutes of Health |
| Dr. Anthony S. Fauci | Director, National Institute of Allergy and Infectious Diseases |
| Dr. Jack Whitescarver | Director, Office of AIDS Research |
| Dr. Nora Volkow | Director, National Institute on Drug Abuse |
| Dr. Carl Dieffenbach | Director, Division of AIDS, National Institute of Allergy and Infectious Diseases |
| Dr. Avindra Nath | Intramural Clinical Director, National Institute of Neurological Disorders and Stroke |
| Dr. Robert Yarchoan | Director, Office of HIV and AIDS Malignancy, National Cancer Institute |
| Dr. Basil Eldadah | Acting Chief, Geriatrics Branch, National Institute on Aging |
| Dr. Bill Kapogiannis | Medical Officer, Eunice Kennedy Shriver National Institute of Child Health and Human Development |
| Dr. Gina Brown | NIH Office of AIDS Research |
| Dr. Victoria Cargill | NIH Office of AIDS Research |
| Mark Harrington | Executive Director, Treatment Action Group |